| Literature DB >> 30079028 |
Ruud H Knols1, Nicolas Fischer1,2, Dario Kohlbrenner3, Anastasios Manettas3, Eling D de Bruin2,4.
Abstract
Introduction: This systematic review aimed to assess the replicability of physical exercise interventions in lung transplantation patients. For replicability we focused on (1) the description of training principles, (2) the description of FITT components and adherence to the interventions, (3) the amount of detailed information given on the physical exercise intervention, and (4) reporting the methodological quality of the included works.Entities:
Keywords: adherence; exercise; lung transplant; methodological; systematic review; tidier checklist
Year: 2018 PMID: 30079028 PMCID: PMC6062962 DOI: 10.3389/fphys.2018.00946
Source DB: PubMed Journal: Front Physiol ISSN: 1664-042X Impact factor: 4.566
Overview of the included studies.
| LTX-candidates (COPD, PF, EMPH, A1AD, BO) waiting list ( | MedX clinical lumbar extension machine; to improve bone mineral density (BMD) in TPL patients with Osteoporosis. | 2 Months after LTX start of 6-month resistive strength exercise program. Frequency: 1x/wk, 1 series, 15 up to 20 repetitions through 72 degrees ROM. Non-exercising control group. | BMD lumbar spine, Lumbar extensor strength, AE: Lung Rejection. | CG: Sign. decrease of BMD from 2 up to 8 Months after LTX) below BMD baseline.IT: Sign. improvement of BMD returning to BMD baseline values (ES = 0.52, | |
| LTX-candidates (COPD, PF, EMPH, A1AD, BO & PH) waiting list, | MedX clinical lumbar extension machine; to improve bone mineral density (BMD) in combination with alendronate or single Alodronate intervention in TPL patients with Osteoporosis. | 2 Months after LTX start of 6-month resistive strength exercise program. Frequency: 1x/wk, 1 series, 15 up to 20 repetitions through 72 degrees ROM. The patients in the single Alodronate Group& CG did not participate in a training program. | BMD lumbar spine, Lumbar extensor strength, AE: Lung Rejection. | BMD: Sign. decrease of BMD from 2 up to 8 Months in CG after LTX below BMD baseline. No significant decrease in the single Alodronate group from baseline to 2 months. BMD improved sign. in combined Alendronate & EG (ES = 1.09, | |
| 60 patients 5 years. after transplant, (34 women, 16 men), 30 patients in EG, 30 in CT. Age between 49 and 50. | Exercise training: endurance training; upper and lower limb strength training; Stretches major muscle groups: incl. calf, biceps, hamstrings, quadriceps; range-of-motion exercises of the neck, shoulder and trunk & education program. | Inpatient 5 h of supervised training; 30 min. breathing exercises 30 min. group-aerobic 5x/wk.; education. Pat received endurance, strength; stretching training vs. outpatient CT received standard-physiotherapy. | Cardio-pulmonic exercise testing, 6MWT, SF-36, SGRQ, HRQOL. | Endurance and HRQOl improved in both groups, but there were no sign. group differences for cardio-pulmonary exercise testing nor 6 MWT or any other outcome. | |
| 34 patients after uncomplicated LTX (≤ 6 wks. in hospital (18 woman, 16 men), 18 in IT (9 women, 9 men) & 16 in CT (9 woman, 7 men) age 59 (SD 4) years. | Stationary bicycle & leg press. | 12 wk. physical exercise training intervention 3x/wk. initially at 60% for cycling training and 75% for treadmill training. Cycling, walking, climbing stairs, und strength training during 90 min per training. CT received no exercise. | Walking time & intensity, steps/day, 6MWT, Quadriceps& grip strength, inspiratory muscle strength, HRQoL, SF-36. | Sig. difference between EG and CG immediately after the exercise intervention were found for walking time (ES = 0.77, | |
| 83 patients 10 (12) wks. post LTX), (41 women, 42 men), 44 WBVT-EG, 39 CG, Age 55 (SD 9) | Stationary bicycle, Vibrationplatform (Galileo, Novotec Medical GmbH, Pforzheim, Germany | 4 wk. in-hospital exercise program. 5-6x/wk.Included medical care, exercise training, breathing therapy, special LTX education, nutritional counseling and psychological support. Endurance training (15 min.) at 60% of peak workrate, strength training (4–5 exercisers for majormuscle groups, 3 x 20 min). Additional 4 x 2 min. Squattraining with vibrations (WBVT-group) or without vibration (CG). | Primary Outcome: 6MWT Sec. outcome PWR, STST, max. muscle strength, HRQoL (CRQ, HADS) | Improvement in 6MWD was sign. (ES = 0.54, | |
| 66 patients after LTX, (33 woman, 33 men, age between 38-64 years randomized in 7 wk. and 14 wk. PE program. | Stationary bicycle, treadmill, resistive strength machines or weights. | 3x/ wk. 60 min.: Endurance (30 min.) & strength training. Home exercise in 7-wk. group on a stationary bicycle or walking and strength exercises. The home exercise group received education during the first seven wks. | Primary outcome: 6MWT Secondary outcome: Quadriceps and hamstrings strength, HRQol | 6MWD improved in both groups with no sign.difference between groups at any time point. Similarly, at 6 months, there was no difference between groups in quadriceps and hamstring strength or mental or physical health domains of HRQoL. | |
| 80 LTX patients, (43 woman, 37 men, age 45–68 years | Supervised lower limb endurance training incl. treadmill walking and cycle ergometry, & lower limb strength training. | LTX patients randomized randomized in: (1) no supervised upper limb program (NULP) or (2) structured, supervised upper limb program (SULP). 12 week training, 3x/wk. 60 min.: Endurance (30 min.) & group strength training. | Primary outcome: Overall bodily pain (VAS) Secondary outcome: Sf-36, Bodily pain, Strength, Quick Dash & MWT Bodily pain site | VAS bodily pain improved in NULP & SULP over all time points:group x time interaction ( |
6MWT, 6-Minute-Walking Test; A1AD, Anti alpha1 antitrypsin deficiency; AE, Adverse effects (lung rejection); BMD, Bone mineral density; BO, Bronchiolitis obliterans; CG, Control group; COPD, Chronic Obstructive Pulmonary Disease; CRQ, Chronic Respiratory Questionnaire; CT, Continuous exercise Training; EG, Exercise Group: EMPH, Emphysema; ES, effect size; HADS, Hospital Anxiety and Depression Scale; HRQoL, Health related quality of life; IG, Interventiongroup; IT, Intervall Training; LTX, lung transplantation; NULP, NO supervised exercise; PF, Pulmonary fibrosis; PH, Pulmonary hypertension; PWR, Peak work rate; QoL, Quality of Life; QWB, Quality of well-being scale; ROM, Range of Motion; SF-36, 36-Item Short Form Survey; SGRQ, St. George's Respiratory Questionnaire; Sign., Significant; STST, Sit-to-stand Test; SULP, Supervised upper limb exercise program; US, Ultra Sound; VAS, Visual Analog Scale; WBVT, Whole-body vibration training; wk., week.
Description of reporting of the principles of exercise training.
| Mitchell et al., | 1 | 1 | 1 | 1 | 0 | 0 | 4 |
| Braith et al., | 1 | 1 | 1 | 1 | 0 | 0 | 4 |
| Ihle et al., | 1 | 0 | 0 | 1 | 0 | 0 | 2 |
| Langer et al., | 1 | 1 | 1 | 1 | 0 | 0 | 4 |
| Gloeckl et al., | 1 | 1 | 1 | 1 | 0 | 0 | 4 |
| Fuller et al., | 1 | 1 | 1 | 1 | 0 | 0 | 4 |
| Fuller et al., | 1 | 1 | 1 | 1 | 1 | 0 | 5 |
| Total | 7 | 6 | 6 | 7 | 1 | 0 |
Clear description of training principle = 1; Unclear or no description of training principle = 0.
Reporting of planned FITT (gray) and adherence FITT components (white).
| Mitchell et al., | 0 | 1 | 0 | 1 | 2 | 0 | 0 | 0 | 0 | 0 |
| Braith et al., | 0 | 1 | 0 | 1 | 2 | 0 | 0 | 0 | 0 | 0 |
| Ihle et al., | 0 | 0 | 0 | 1 | 1 | 0 | 0 | 0 | 0 | 0 |
| Langer et al., | 0 | 1 | 1 | 1 | 3 | 0 | 0 | 0 | 0 | 0 |
| Gloeckl et al., | 0 | 0 | 0 | 1 | 1 | 0 | 0 | 0 | 0 | 0 |
| Fuller et al., | 0 | 0 | 0 | 1 | 1 | 0 | 0 | 0 | 0 | 0 |
| Fuller et al., | 0 | 1 | 0 | 1 | 2 | 0 | 0 | 0 | 0 | 0 |
| Total | 0 | 4 | 1 | 7 | – | 0 | 0 | 0 | 0 | 0 |
1, FITT component reported; 0, FITT component not reported or unclear/inconsistently reported.
FITT, Frequency, Intensity, Time Type; RCT, Randomized controlled trial.
Description of the intervention details (TIDieR- Checklist).
| 1 | + | + | + | + | + | + | + | 7 |
| 2 | + | + | + | + | + | + | + | 7 |
| 3 | + | + | – | ? | ? | ? | ? | 2 |
| 4 | ? | ? | ? | + | + | + | ? | 3 |
| 5 | + | – | – | – | – | ? | + | 2 |
| 6 | ? | ? | ? | ? | ? | ? | ? | 0 |
| 7 | - | ? | ? | ? | ? | + | + | 2 |
| 8 | ? | ? | ? | ? | ? | ? | ? | 0 |
| 9 | + | ? | – | ? | ? | ? | ? | 1 |
| 10 | – | – | – | – | – | – | – | 0 |
| 11 | – | – | – | – | ? | ? | ? | 0 |
| 12 | – | – | – | – | ? | ? | – | 0 |
| Total per Study | 5 | 3 | 2 | 3 | 3 | 4 | 4 |
+, Item reported; ?, unclear or inconsistently reported; –, Item not reported.
Downs and black methodological quality list.
| Mitchell et al., | 1 | 1 | 0 | 0 | 1 | 1 | 1 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 1 | 1 | 1 | 0 | 1 | 1 | 0 | 1 | 0 | 0 | 0 | 0 | 11 | 28 | 39.3 |
| Braith et al., | 1 | 1 | 0 | 0 | 1 | 1 | 1 | 1 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 1 | 1 | 0 | 1 | 0 | 0 | 1 | 0 | 0 | 0 | 0 | 10 | 28 | 35.7 |
| Ihle et al., | 1 | 1 | 1 | 0 | 1 | 1 | 1 | 0 | 1 | 1 | 1 | 0 | 0 | 0 | 0 | 1 | 1 | 1 | 0 | 1 | 1 | 1 | 1 | 0 | 0 | 1 | 0 | 17 | 28 | 60.7 |
| Langer et al., | 1 | 1 | 1 | 0 | 1 | 1 | 1 | 0 | 0 | 1 | 1 | 0 | 1 | 0 | 1 | 1 | 1 | 1 | 0 | 1 | 1 | 1 | 1 | 1 | 0 | 0 | 1 | 19 | 28 | 67.9 |
| Gloeckl et al., | 1 | 1 | 1 | 0 | 1 | 1 | 1 | 1 | 0 | 1 | 1 | 0 | 0 | 0 | 1 | 1 | 1 | 1 | 0 | 1 | 0 | 1 | 1 | 1 | 0 | 0 | 1 | 18 | 28 | 64.3 |
| Fuller et al., | 1 | 1 | 1 | 0 | 1 | 1 | 1 | 1 | 1 | 1 | 1 | 0 | 1 | 0 | 1 | 1 | 1 | 1 | 0 | 1 | 1 | 0 | 1 | 1 | 1 | 1 | 1 | 22 | 28 | 78.6 |
| Fuller et al., | 1 | 1 | 1 | 0 | 1 | 1 | 1 | 1 | 1 | 1 | 1 | 0 | 1 | 0 | 1 | 1 | 1 | 1 | 1 | 1 | 1 | 0 | 1 | 1 | 1 | 1 | 0 | 22 | 28 | 78.6 |
| Total | 7 | 7 | 5 | 0 | 7 | 7 | 7 | 4 | 3 | 5 | 5 | 0 | 3 | 0 | 4 | 6 | 7 | 7 | 1 | 7 | 5 | 3 | 7 | 4 | 2 | 3 | 3 | |||
T, Scored points; P, Maximum points, %, Percentage.
Figure 1Flowchart of the systematic review. RCT, randomized controlled trial; LTX Lungtransplantation.